Bafna Pharmaceuticals standalone net profit rises 15.47% in the June 2021 quarter

Sales rise 27.31% to Rs 21.26 crore
Net profit of Bafna Pharmaceuticals rose 15.47% to Rs 2.09 crore in the quarter ended June 2021 as against Rs 1.81 crore during the previous quarter ended June 2020. Sales rose 27.31% to Rs 21.26 crore in the quarter ended June 2021 as against Rs 16.70 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales21.2616.70 27 OPM %16.4215.57 -PBDT3.552.76 29 PBT2.091.81 15 NP2.091.81 15Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 05 2021 | 3:29 PM IST
